FindTrial
Sign In

The Clinical Significance and Molecular Characteristics of TLS in Esophageal Squamous Cell Carcinoma

The Clinical Significance and Molecular Characteristics of TLS in Esophageal Squamous Cell Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101699
Enrollment
Unknown
Registered
2025-04-28
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

Newly diagnosed esophageal squamous cell carcinoma group:None

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient has completed R0 resection; 2. The patient has not received systemic therapy; 3. The patient was pathologically diagnosed with primary TxNxM0 esophageal squamous cell carcinoma according to the 8th edition TNM classification.

Exclusion criteria

Exclusion criteria: Patients who suffered from autoimmune disease or concurrent multiple primary tumors

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Recurrence-free survival;—

Countries

China

Contacts

Public ContactYongbing Chen

the Second Affiliated Hospital of Soochow University

chentongt@sina.com+86 135 0353 6679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026